TFF PHARMACEUTICALS, INC. Operating Income
TFF PHARMACEUTICALS, INC. reported Operating Income of -$3.58 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-09-30 was -$3.58M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-06-30 was -$3.96M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-03-31 was -$5.79M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2023-12-31 was -$5.37M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$21.89M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$31.80M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for fiscal 2021 was -$31.79M.
- TFF PHARMACEUTICALS, INC. operating income (loss) for fiscal 2020 was -$18.69M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 8 month | Operating Income (Loss) 9 month | Operating Income (Loss) 11 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$3.58M 10-Q · filed 2024-11-20 | -$7.54M derived: sum of 2 quarters · filed 2024-11-20 | -$13.34M 10-Q · filed 2024-11-20 | -$18.70M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-06-30 | -$3.96M 10-Q · filed 2024-08-14 | -$9.75M 10-Q · filed 2024-08-14 | -$15.12M derived: sum of 3 quarters · filed 2024-08-14 | -$19.54M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-03-31 | -$5.79M 10-Q · filed 2024-05-14 | -$11.16M derived: sum of 2 quarters · filed 2024-05-14 | -$15.58M derived: sum of 3 quarters · filed 2024-11-20 | -$20.60M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-12-31 | -$5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$9.79M derived: sum of 2 quarters · filed 2024-11-20 | -$14.81M derived: sum of 3 quarters · filed 2024-11-20 | -$21.89M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | -$4.42M 10-Q · filed 2024-11-20 | -$9.44M derived: sum of 2 quarters · filed 2024-11-20 | -$16.53M 10-Q · filed 2024-11-20 | -$23.91M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-06-30 | -$5.02M 10-Q · filed 2024-08-14 | -$12.11M 10-Q · filed 2024-08-14 | -$19.49M derived: sum of 3 quarters · filed 2024-08-14 | -$26.77M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$7.09M 10-Q · filed 2024-05-14 | -$14.47M derived: sum of 2 quarters · filed 2024-05-14 | -$21.75M derived: sum of 3 quarters · filed 2024-05-14 | -$30.50M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$14.66M derived: sum of 2 quarters · filed 2024-03-28 | -$23.41M derived: sum of 3 quarters · filed 2024-03-28 | -$31.80M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$7.28M 10-Q · filed 2023-11-14 | -$16.03M derived: sum of 2 quarters · filed 2023-11-14 | -$24.42M 10-Q · filed 2023-11-14 | -$34.51M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$8.75M 10-Q · filed 2023-08-14 | -$8.77M 10-Q · filed 2022-08-11 | -$17.14M 10-Q · filed 2023-08-14 | -$17.21M 10-Q · filed 2022-08-11 | -$27.23M derived: sum of 3 quarters · filed 2023-08-14 | -$35.91M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$8.38M 10-Q · filed 2023-05-11 | -$8.44M 10-Q · filed 2022-05-11 | -$18.48M derived: sum of 2 quarters · filed 2023-05-11 | -$27.16M derived: sum of 3 quarters · filed 2023-05-11 | -$32.27M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.77M derived: sum of 2 quarters · filed 2023-03-31 | -$23.89M derived: sum of 3 quarters · filed 2023-03-31 | -$31.79M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$8.68M 10-Q · filed 2022-11-14 | -$13.79M derived: sum of 2 quarters · filed 2022-11-14 | -$21.69M 10-Q · filed 2022-11-14 | -$27.61M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$5.11M 10-Q · filed 2022-08-11 | -$13.01M 10-Q · filed 2022-08-11 | -$18.93M derived: sum of 3 quarters · filed 2022-08-11 | -$24.01M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$7.90M 10-Q · filed 2022-05-11 | -$13.82M derived: sum of 2 quarters · filed 2022-05-11 | -$18.90M derived: sum of 3 quarters · filed 2022-05-11 | -$22.74M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$11.00M derived: sum of 2 quarters · filed 2022-03-24 | -$14.84M derived: sum of 3 quarters · filed 2022-03-24 | -$18.69M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$5.08M 10-Q · filed 2021-11-15 | -$8.92M derived: sum of 2 quarters · filed 2021-11-15 | -$12.77M 10-Q · filed 2021-11-15 | -$17.49M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.84M 10-Q · filed 2021-08-12 | -$7.70M 10-Q · filed 2021-08-12 | -$12.41M derived: sum of 3 quarters · filed 2021-08-12 | -$15.27M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$3.85M 10-Q · filed 2021-05-13 | -$8.57M derived: sum of 2 quarters · filed 2021-05-13 | -$11.43M derived: sum of 3 quarters · filed 2021-05-13 | -$13.64M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$7.58M derived: sum of 2 quarters · filed 2021-03-10 | -$9.79M derived: sum of 3 quarters · filed 2021-03-10 | -$11.99M 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | -$2.86M 10-Q · filed 2020-11-05 | -$5.07M derived: sum of 2 quarters · filed 2020-11-05 | -$7.28M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$2.21M 10-Q · filed 2020-08-13 | -$4.41M 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | -$2.20M 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | -$3.90M 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | -$606.09K 10-Q · filed 2019-12-09 | -$3.00M 10-Q · filed 2019-12-09 |